Kolexia
Lacroix Ludovic
Pharmacien
Gustave-Roussy
Villejuif, France
349 Activités
274 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Carcinomes Tumeurs du sein Tumeurs de la thyroïde Métastase tumorale Mélanome Carcinome épidermoïde

Industries

Lilly
7 collaboration(s)
Dernière en 2020
Janssen
4 collaboration(s)
Dernière en 2023
AstraZeneca
3 collaboration(s)
Dernière en 2021
Taiho Oncology
2 collaboration(s)
Dernière en 2021

Dernières activités

Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients.
NPJ precision oncology   26 février 2024
SAFIR02_Breast: PERSONALIZED MEDICINE GROUP / UCBG UC-0105/1304: SAFIR02_Breast - Evaluation of the Efficacy of High Throughput Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer
Essai Clinique (Unicancer)   09 janvier 2024
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma.
JCO precision oncology   25 décembre 2023
DAISY: Phase II, Open Label Study of DS-8201a, an Anti-HER2-antibody Drug Conjugate (ADC) for Advanced Breast Cancer Patients, With Biomarkers Analysis to Characterize Response/Resistance to Therapy
Essai Clinique (Daiichi Sankyo)   06 décembre 2023
Impact thérapeutique du profilage moléculaire des patients atteints de mélanome résistant au traitement standard : résultats « en vie réelle »
Journées dermatologiques de Paris 2023   01 décembre 2023
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8 T cells in patients with advanced NSCLC.
Science advances   08 novembre 2023
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study.
Thyroid : official journal of the American Thyroid Association   07 novembre 2023
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid.
Molecular cancer   06 novembre 2023
Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study.
Molecular cancer   04 novembre 2023
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors.
Clinical cancer research : an official journal of the American Association for Cancer Research   02 novembre 2023